1. Home
  2. HOWL vs MATH Comparison

HOWL vs MATH Comparison

Compare HOWL & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • MATH
  • Stock Information
  • Founded
  • HOWL 2017
  • MATH 2015
  • Country
  • HOWL United States
  • MATH Hong Kong
  • Employees
  • HOWL N/A
  • MATH N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • MATH Finance/Investors Services
  • Sector
  • HOWL Health Care
  • MATH Finance
  • Exchange
  • HOWL Nasdaq
  • MATH Nasdaq
  • Market Cap
  • HOWL 53.4M
  • MATH 60.8M
  • IPO Year
  • HOWL 2021
  • MATH N/A
  • Fundamental
  • Price
  • HOWL $1.10
  • MATH $3.00
  • Analyst Decision
  • HOWL Strong Buy
  • MATH
  • Analyst Count
  • HOWL 3
  • MATH 0
  • Target Price
  • HOWL $8.33
  • MATH N/A
  • AVG Volume (30 Days)
  • HOWL 648.5K
  • MATH 320.1K
  • Earning Date
  • HOWL 08-07-2025
  • MATH 08-26-2025
  • Dividend Yield
  • HOWL N/A
  • MATH N/A
  • EPS Growth
  • HOWL N/A
  • MATH N/A
  • EPS
  • HOWL N/A
  • MATH 0.17
  • Revenue
  • HOWL $1,143,000.00
  • MATH $31,399,049.00
  • Revenue This Year
  • HOWL N/A
  • MATH N/A
  • Revenue Next Year
  • HOWL N/A
  • MATH N/A
  • P/E Ratio
  • HOWL N/A
  • MATH $17.74
  • Revenue Growth
  • HOWL N/A
  • MATH 291.58
  • 52 Week Low
  • HOWL $0.60
  • MATH $0.80
  • 52 Week High
  • HOWL $4.18
  • MATH $4.17
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 46.17
  • MATH 47.33
  • Support Level
  • HOWL $1.18
  • MATH $2.88
  • Resistance Level
  • HOWL $1.30
  • MATH $3.14
  • Average True Range (ATR)
  • HOWL 0.12
  • MATH 0.32
  • MACD
  • HOWL -0.03
  • MATH -0.12
  • Stochastic Oscillator
  • HOWL 6.33
  • MATH 20.69

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

Share on Social Networks: